Cargando…
Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study
Background: This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Methods: Population-based cohort, including women who breastfed (n = 39...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014443/ https://www.ncbi.nlm.nih.gov/pubmed/31963112 http://dx.doi.org/10.3390/ijerph17020568 |
_version_ | 1783496631541301248 |
---|---|
author | Lutz, Bárbara Heather Bassani, Diego Garcia Miranda, Vanessa Iribarrem Avena Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Dal Pizzol, Tatiane da Silva da Silveira, Mariângela Freitas Bertoldi, Andréa Dâmaso |
author_facet | Lutz, Bárbara Heather Bassani, Diego Garcia Miranda, Vanessa Iribarrem Avena Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Dal Pizzol, Tatiane da Silva da Silveira, Mariângela Freitas Bertoldi, Andréa Dâmaso |
author_sort | Lutz, Bárbara Heather |
collection | PubMed |
description | Background: This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Methods: Population-based cohort, including women who breastfed (n = 3988). Medications were classified according to Hale’s lactation risk categories and Brazilian Ministry of Health criteria. Duration of breastfeeding was analysed using Cox regression models and Kaplan-Meier curves, including only women who were still breastfeeding at three months postpartum. Results: Medication use with some risk for lactation was frequent (79.6% regarding Hale’s risk categories and 12.3% regarding Brazilian Ministry of Health criteria). We did not find statistically significant differences for weaning at 6 or 12 months between the group who did not use medication or used only compatible medications and the group who used medications with some risk for lactation, according to both criteria. Conclusions: Our study found no association between weaning rates across the different breastfeeding safety categories of medications in women who were still breastfeeding at three months postpartum. Therefore, women who took medications and stopped breastfeeding in the first three months postpartum because of adverse side-effects associated with medications could not be addressed in this analysis. |
format | Online Article Text |
id | pubmed-7014443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70144432020-03-09 Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study Lutz, Bárbara Heather Bassani, Diego Garcia Miranda, Vanessa Iribarrem Avena Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Dal Pizzol, Tatiane da Silva da Silveira, Mariângela Freitas Bertoldi, Andréa Dâmaso Int J Environ Res Public Health Article Background: This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Methods: Population-based cohort, including women who breastfed (n = 3988). Medications were classified according to Hale’s lactation risk categories and Brazilian Ministry of Health criteria. Duration of breastfeeding was analysed using Cox regression models and Kaplan-Meier curves, including only women who were still breastfeeding at three months postpartum. Results: Medication use with some risk for lactation was frequent (79.6% regarding Hale’s risk categories and 12.3% regarding Brazilian Ministry of Health criteria). We did not find statistically significant differences for weaning at 6 or 12 months between the group who did not use medication or used only compatible medications and the group who used medications with some risk for lactation, according to both criteria. Conclusions: Our study found no association between weaning rates across the different breastfeeding safety categories of medications in women who were still breastfeeding at three months postpartum. Therefore, women who took medications and stopped breastfeeding in the first three months postpartum because of adverse side-effects associated with medications could not be addressed in this analysis. MDPI 2020-01-16 2020-01 /pmc/articles/PMC7014443/ /pubmed/31963112 http://dx.doi.org/10.3390/ijerph17020568 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lutz, Bárbara Heather Bassani, Diego Garcia Miranda, Vanessa Iribarrem Avena Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Dal Pizzol, Tatiane da Silva da Silveira, Mariângela Freitas Bertoldi, Andréa Dâmaso Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study |
title | Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study |
title_full | Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study |
title_fullStr | Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study |
title_full_unstemmed | Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study |
title_short | Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study |
title_sort | use of medications by breastfeeding women in the 2015 pelotas (brazil) birth cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014443/ https://www.ncbi.nlm.nih.gov/pubmed/31963112 http://dx.doi.org/10.3390/ijerph17020568 |
work_keys_str_mv | AT lutzbarbaraheather useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy AT bassanidiegogarcia useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy AT mirandavanessairibarremavena useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy AT silveiramarysabelpintotelis useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy AT menguesoteroserrate useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy AT dalpizzoltatianedasilva useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy AT dasilveiramariangelafreitas useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy AT bertoldiandreadamaso useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy |